| Patents for A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707) |
|---|
| 09/17/2013 | CA2673646C Formation of medically useful gels comprising microporous particles and methods of use |
| 09/12/2013 | WO2013133413A1 Mucosa-elevating agent |
| 09/11/2013 | CN103285030A Xanthan gum-containing anti-blocking preparation |
| 09/10/2013 | US8530407 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 09/04/2013 | CN103271939A Anti-adhesion flushing fluid for operation |
| 08/28/2013 | CN103263434A Anti-adhesion liquor for wound washing and surgery and preparation method and application of anti-adhesion liquor |
| 08/21/2013 | CN103254448A Medical sodium hyaluronate gel and preparation method thereof |
| 08/20/2013 | US8515560 Medical implant drug delivery device |
| 08/20/2013 | CA2488558C Prevention and reduction of blood loss |
| 08/14/2013 | EP2624874A1 Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications |
| 08/07/2013 | CN101618045B Anti-adhesion gel containing polyhydroxyalkanoate |
| 08/06/2013 | CA2690686C Amine compound and pharmaceutical use thereof |
| 07/31/2013 | CN103228285A Priming solutions for cardiopulmonary bypass |
| 07/25/2013 | WO2013109811A1 Human placental derived extracellular matrix and uses thereof |
| 07/23/2013 | CA2536415C Crosslinking reagent for treating intervertebral disc disorders |
| 07/17/2013 | CN103203014A Preparation method of blended functional surgical irrigating fluid |
| 07/17/2013 | CN102441179B Silicon dioxide base ultrasonic contrast medium/high intensity focused ultrasound (HIFU) synergist and preparation method thereof |
| 07/16/2013 | CA2498213C Induction of gene expression using a high concentration sugar mixture |
| 07/16/2013 | CA2448348C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 06/26/2013 | EP2605762A1 Compositions comprising adipose tissue and a pge2 analogue and their use in the treatment of a soft tissue condition |
| 06/25/2013 | CA2564161C Melatonin and its use in preventing postoperative complications |
| 06/20/2013 | US20130156696 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse |
| 06/19/2013 | EP2603221A2 Ggf2 and methods of use |
| 06/19/2013 | CN103168036A Soft cationic mitochondrial uncouplers |
| 06/13/2013 | US20130150436 Polyacetylene compound, an extract containing the same and application thereof |
| 06/12/2013 | EP2601201A1 Process for preparation of novel 42-0-(heteroalkoxyalkyl) rapamycin compounds with anti-proliferative properties" |
| 06/11/2013 | US8461104 Surface protection of exposed biological tissues |
| 06/11/2013 | CA2426987C Human cord blood derived unrestricted somatic stem cells (ussc) |
| 06/06/2013 | US20130144370 Cochlear implant drug delivery device |
| 06/05/2013 | CN103140494A Process for preparation of novel 42-0-(heteroalkoxyalkyl) rapamycin compounds with anti-proliferative properties |
| 06/04/2013 | US8455464 Dextrin containing compositions for prevention of adhesions |
| 05/28/2013 | US8449902 Methods for producing biomaterials with variable stiffness |
| 05/22/2013 | CN103110571A Medical sodium hyaluronate gel |
| 05/14/2013 | CA2419469C Derivatives of peptides and peptide mimetics having integrin inhibitor properties ii |
| 05/10/2013 | WO2013032201A3 Material for preventing adhesion, and method for preventing adhesion |
| 05/08/2013 | CN103096903A The therapeutic use of tetrathiomolybdate |
| 05/08/2013 | CN102512573B Nursing liquid for promoting wound healing |
| 05/01/2013 | EP2586776A1 Soft cationic mitochondrial uncouplers |
| 05/01/2013 | CN103070859A Lavage fluid comprising ascorbic acid or salt thereof, and purpose thereof |
| 05/01/2013 | CN101378766B Composition for inhibiting adhesion |
| 04/24/2013 | CN103054816A Aprotinin freeze-dried powder and preparation method thereof |
| 04/24/2013 | CN102488908B Flushing fluid for electrocision and application of same |
| 04/17/2013 | CN1917899B Use of alkaline phosphatase for the detoxification of lps |
| 04/17/2013 | CN103041448A Compound polysaccharide hemostatic material and preparation method and application thereof |
| 04/17/2013 | CN103041441A Application method of medical biocolloid liquid |
| 04/10/2013 | CN101837006B Application of PCL-PEG-PCL tri-block copolymer in preparation of medical anti-blocking material |
| 04/03/2013 | CN103006695A Intraocular perfusate and preparation method thereof |
| 04/03/2013 | CN103006544A Preparation method of high-viscoelasticity sodium hyaluronate gel |
| 04/02/2013 | CA2452529C Use of a blood-flow decrease preventing agent in conjunction with insufflating gas |
| 03/28/2013 | US20130078243 Conjugate molecule |
| 03/21/2013 | US20130072435 Tribonectins |
| 03/20/2013 | CN102973941A Polymer hydrogel loading chemotherapy drug, and application thereof in preventing tumor recurrence and preventing and treating postoperative abdominal adhesion |
| 03/20/2013 | CN102107024B Device for delivering powder to wound |
| 03/19/2013 | US8399414 Analgesics |
| 03/19/2013 | CA2488499C Nanoparticulate formulations comprising hmg coa reductase inhibitor derivatives ("statins"),combinations thereof as well as manufacturing of these pharmaceutical compositions |
| 03/14/2013 | WO2012101524A3 Radiopaque embolic particles |
| 03/14/2013 | US20130064795 Immune modulation |
| 03/07/2013 | WO2013032201A2 Material for preventing adhesion, and method for preventing adhesion |
| 03/07/2013 | US20130059773 Compounds for the treatment of inflammation and neutropenia |
| 03/07/2013 | US20130059009 Compositions and methods for producing antigen-specific induced tolerogenic dendritic cells with synthetic nanocarriers |
| 03/06/2013 | CN102949754A Uterine cavity hemostasis anti-adhersion temperature-sensitive gel and preparation method thereof |
| 02/21/2013 | US20130045964 Mandelamide heterocyclic compounds |
| 02/20/2013 | EP2558106A1 Methods and compositions for improving implant osseointegration |
| 02/19/2013 | US8377893 Highly purified antiendotoxin compound |
| 02/14/2013 | US20130041006 Pharmaceutical composition for intracellar acidification with cis-urocanic acid |
| 02/14/2013 | US20130040911 Adhesion-preventing material |
| 02/13/2013 | EP2556834A1 The therapeutic use of tetrathiomolybdate |
| 02/13/2013 | CN102933258A Radiotherapy combined with hypoxic cell sensitizers |
| 02/12/2013 | CA2429817C Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
| 02/12/2013 | CA2366880C Compositions of polyacids and polyethers and methods for their use in reducing adhesions |
| 02/07/2013 | WO2013018864A1 Anti-adhesion membrane |
| 02/07/2013 | WO2013018759A1 Anti-adhesion medical material and method for producing same |
| 02/06/2013 | EP2552938A1 Amphiphilic linear peptide/peptoid and hydrogel comprising the same |
| 02/06/2013 | EP2552461A1 The therapeutic use of tetrathiomolybdate |
| 01/29/2013 | CA2640409C Composition for inhibiting adhesion |
| 01/24/2013 | US20130022629 Modulators of Immunoinhibitory Receptor PD-1, and Methods of Use Thereof |
| 01/17/2013 | US20130018036 Substituted indazole derivatives active as kinase inhibitors |
| 01/09/2013 | EP2543385A1 Novel analgesics |
| 01/09/2013 | EP2542307A1 Radiotherapy combined with hypoxic cell sensitizers |
| 01/08/2013 | CA2423595C Plasminogen activator to prevent corneal and subepithelial haze after laser vision correction surgery |
| 01/08/2013 | CA2385498C Method to enhance healing of sternum after sternotomy |
| 01/03/2013 | US20130004416 Dual Variable Domain Immunoglobulin and Uses Thereof |
| 12/27/2012 | US20120328661 Coumarin compounds as receptor modulators with therapeutic utility |
| 12/26/2012 | CN102844033A Methods and compositions for improving implant osseointegration |
| 12/26/2012 | CN102836171A Solution for surgery and endoscope washing and preparation method thereof |
| 12/13/2012 | US20120316170 Imidazole Derivative |
| 12/12/2012 | CN102813758A Anorectal administration drug |
| 12/06/2012 | US20120309784 Triazolopyridine kinase inhibitors useful for the treatment of degenerative and inflammatory diseases |
| 12/06/2012 | US20120308589 Sinomenine derivatives, synthetic methods and uses thereof |
| 12/06/2012 | US20120308515 Use of gilz protein expressed in dendritic cells to modulate an antigen-specific immune response |
| 11/29/2012 | US20120301515 Anti-adhesion material |
| 11/29/2012 | US20120301486 Compositions and methods for inhibition of the jak pathway |
| 11/28/2012 | CN102793952A Gel material for preventing intestinal adhesion |
| 11/22/2012 | WO2012156938A1 Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process |
| 11/22/2012 | US20120295961 Modulation of hepatitis b virus (hbv) expression |
| 11/22/2012 | US20120295956 Prevention of tissue ischemia and related methods |
| 11/22/2012 | US20120291789 Medical composition for protuberance of epithelium |
| 11/22/2012 | CA2836268A1 Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process |
| 11/21/2012 | CN101804066B Application of MPEG-PLA (Methoxypolyethylene Glycols-Polylactic Acid) diblock copolymers in preparation of medical anti-blocking material |
| 11/14/2012 | CN102772426A Medical applications of chitosan serving as component of parturition assistant lubricating agent |